Company
United StatesPublic company, NASDAQ: LINLinde, PLC (NASDAQ: LIN), Springfield, MO – FDA Inspections
Inspection records and compliance data for Linde, PLC in Springfield, MO. 1 FDA inspection on record, last inspected May 01, 2025. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde, PLC based in Springfield, MO, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected May 1, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 1, 2025 | Not classified | Foods & Cosmetics | 1268814 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde, PLC
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3007160366
Address
2135 E Mcdaniel St, Springfield, MO 65802-2928, United States
Country
United States
ID: ef4762be-2251-4fc6-8d4c-4d3aeb4e0489